People with pernicious anemia
Canagliflozin reduced the risk of the primary composite outcome (ESKD, doubling of serum creatinine, or renal or cardiovascular death) by 30% compared to placebo, with consistent effects across all prespecified subgroups [46]
A Review of N-Acetylcysteine in the Treatment of Grooming Disorders, 2019 Tara L Braun MD, Viraat Patel MD, Logan C DeBord BA, Theodore Rosen MD A trial of NAC may be a viable option for pathologic grooming disorders, especially in patients who have failed prior psychologic or pharmacologic treatment
This dose-tolerability relationship provides useful guidance for clinical protocol development
C.WilliamsH
Ways to Combat Facial Side Effects Start with the basics: Stay hydrated and eat a nutrient-rich, protein-forward diet